Bristol Myers Squibb (BMY) stock plunged early Thursday after the drugmaker reported adjusted earnings of $1.67 per share on $12.34 billion in fourth-quarter sales.
↑ X NOW PLAYING How To Buy Stocks: Flat Base Chart PatternOn average, analysts polled by FactSet expected Bristol Myers to earn $1.46 per share and report $11.57 billion in sales.
In the year-earlier period, the pharma company had $1.70 earnings per share and $11.48 billion in sales.
For the year, Bristol Myers guided to earnings of $6.55 to $6.85 per share and $45.5 billion in sales. The Street projected profit of $6.91 per share and $46.29 billion in sales.
In premarket trades on the stock market today, Bristol Myers Squibb stock tumbled more than 4% to 57.25. Shares broke out of a flat base after topping a buy point at 61.08 on Jan. 27, according to MarketSurge. But the stock has since fallen back below that entry.
More to follow.
YOU MAY ALSO LIKE:
Novo Surges As Ozempic Drives Fourth-Quarter Beat. But Supply Shortages Expected.
Amgen Shrugs Off A Surprise Setback For One Of Its Obesity Drugs
Find The Best Long-Term Investments With IBD Long-Term Leaders
Options Trading: How To Start Using Options, How To Manage Risk
Short-Term Trades Can Add Up To Big Profits. IBD's SwingTrader Shows You How
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。